Table 2.
Top 10 down-regulated genes in tumors from mice treated with GLSF compared to control group.
| Gene ID | Gene name | Log FC | P value |
|---|---|---|---|
| Il1b | Interleukin 1 beta | −1.31 | 9.57E-06 |
| Il11 | Interleukin 11 | −1.09 | 4.89E-04 |
| 4930565N06Rik | RIKEN cDNA 4930565N06 gene | −1.06 | 6.84E-04 |
| Nppb | Natriuretic peptide type B | −1.44 | 7.72E-04 |
| Ptgs2 | Prostaglandin-endoperoxide synthase 2 (Cox-2) | −1.11 | 1.18E-03 |
| Mmp10 | Matrix metallopeptidase 10 | −1.51 | 1.31E-03 |
| Mmp13 | Matrix metallopeptidase 13 | −1.16 | 1.68E-03 |
| Stamos | Signal transducing adaptor molecule (SH3 domain and ITAM motif) 1, opposite strand | −1.13 | 1.82E-03 |
| Cxcl1 | Chemokine (C-X-C motif) ligand 1 | −1.56 | 2.07E-03 |
| Mmp12 | Matrix metallopeptidase 12 | −1.03 | 4.01E-03 |
*
Log FC (log2 Fold change) smaller than −1 indicates lower expression in GLSF-treated tumors.